Mustang Bio (MBIO) Short Interest Ratio & Short Volume → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free MBIO Stock Alerts $0.29 +0.01 (+3.58%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Mustang Bio Short Interest DataCurrent Short Volume136,500 sharesPrevious Short Volume178,000 sharesChange Vs. Previous Month-23.31%Dollar Volume Sold Short$51,187.50Short Interest Ratio / Days to Cover0.7Last Record DateApril 15, 2024Outstanding Shares10,390,000 sharesFloat Size7,420,000 sharesShort Percent of Float1.84%Today's Trading Volume37,832 sharesAverage Trading Volume184,996 sharesToday's Volume Vs. Average20% Short Selling Mustang Bio ? Sign up to receive the latest short interest report for Mustang Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMBIO Short Interest Over TimeMBIO Days to Cover Over TimeMBIO Percentage of Float Shorted Over Time Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> Mustang Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024136,500 shares $51,187.50 -23.3%1.8%0.7 $0.38 3/31/2024178,000 shares $185,120.00 -54.2%2.4%1.2 $1.04 3/15/2024389,000 shares $369,550.00 +828.4%5.1%2.7 $0.95 2/29/202441,900 shares $56,565.00 -1.9%0.6%0.3 $1.35 2/15/202442,700 shares $55,937.00 -15.6%0.6%0.8 $1.31 1/31/202450,600 shares $72,864.00 +58.6%0.7%0.8 $1.44 Get the Latest News and Ratings for MBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mustang Bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/202431,900 shares $46,574.00 -53.0%0.4%0.3 $1.46 12/31/202367,800 shares $91,530.00 -18.2%1.0%0.7 $1.35 12/15/202382,900 shares $114,402.00 -4.5%1.2%0.8 $1.38 11/30/202386,800 shares $124,992.00 +15.9%1.4%1 $1.44 11/15/202374,900 shares $121,338.00 -59.9%1.2%1 $1.62 10/31/2023186,700 shares $306,188.00 +571.6%2.7%2.5 $1.64 10/15/202327,800 shares $46,426.00 -53.0%0.5%1.1 $1.67 9/30/202359,200 shares $122,544.00 +166.7%1.1%2.2 $2.07 9/15/202322,200 shares $55,944.00 -59.9%0.4%0.7 $2.52 8/31/202355,400 shares $175,618.00 +60.1%1.0%1.3 $3.17 8/15/202334,600 shares $131,480.00 -19.9%0.6%0.7 $3.80 7/31/202343,200 shares $224,640.00 -45.2%0.8%0.9 $5.20 7/15/202378,800 shares $409,760.00 +47.3%1.5%1.4 $5.20 6/30/202353,500 shares $332,235.00 -19.3%1.0%0.8 $6.21 6/15/202366,300 shares $484,653.00 +10.3%1.2%0.9 $7.31 5/31/202360,100 shares $384,039.00 -38.2%1.1%1 $6.39 5/15/202397,200 shares $422,820.00 -34.7%1.8%1.9 $4.35 4/30/2023148,900 shares $631,336.00 +30.6%2.6%3.1 $4.24 4/15/2023114,000 shares $386,460.00 +850.0%2.0%2.5 $3.39 3/31/202312,000 shares $65,988.00 -91.7%0.2%0.3 $5.50 3/15/2023144,400 shares $57,528.96 -45.3%0.2%0.3 $0.40 2/28/2023264,000 shares $145,200.00 +3.9%0.3%0.5 $0.55 2/15/2023254,200 shares $170,288.58 -13.0%0.3%0.5 $0.67 1/31/2023292,000 shares $197,859.20 -8.5%0.4%0.6 $0.68 1/15/2023319,000 shares $202,469.30 -23.6%0.4%0.6 $0.63 12/30/2022417,700 shares $164,949.73 +4.4%0.5%0.9 $0.39 12/15/2022400,000 shares $151,200.00 +61.4%0.5%1.1 $0.38 11/30/2022247,900 shares $125,189.50 -55.6%0.3%0.7 $0.51 11/15/2022558,300 shares $267,202.38 -5.7%0.7%1.7 $0.48 10/31/2022591,800 shares $320,518.88 +33.1%0.7%1.5 $0.54 10/15/2022444,800 shares $208,833.60 -41.7%0.5%0.8 $0.47 9/30/2022762,400 shares $357,870.56 +4.1%0.9%1.4 $0.47 9/15/2022732,100 shares $427,766.03 +2.4%0.9%1 $0.58 8/31/2022714,800 shares $434,241.00 +25.2%N/A0.8 $0.61Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> MBIO Short Interest - Frequently Asked Questions What is Mustang Bio's current short interest? Short interest is the volume of Mustang Bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 136,500 shares of MBIO short. 1.84% of Mustang Bio's shares are currently sold short. Learn More on Mustang Bio's current short interest. What is a good short interest ratio for Mustang Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MBIO shares currently have a short interest ratio of 1.0. Learn More on Mustang Bio's short interest ratio. What is a good short interest percentage for Mustang Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.84% of Mustang Bio's floating shares are currently sold short. Is Mustang Bio's short interest increasing or decreasing? Mustang Bio saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 136,500 shares, a decrease of 23.3% from the previous total of 178,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mustang Bio's float size? Mustang Bio currently has issued a total of 10,390,000 shares. Some of Mustang Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mustang Bio currently has a public float of 7,420,000 shares. How does Mustang Bio's short interest compare to its competitors? 1.84% of Mustang Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Mustang Bio: Aravive, Inc. (1.81%), Biophytis S.A. (2.62%), Agile Therapeutics, Inc. (12.68%), Cyclacel Pharmaceuticals, Inc. (3.20%), Onconetix, Inc. (2.87%), Virpax Pharmaceuticals, Inc. (1.70%), Altamira Therapeutics Ltd. (3.87%), Avenue Therapeutics, Inc. (32.81%), Clever Leaves Holdings Inc. (0.61%), Notable Labs, Ltd. (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Mustang Bio stock? Short selling MBIO is an investing strategy that aims to generate trading profit from Mustang Bio as its price is falling. MBIO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mustang Bio? A short squeeze for Mustang Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MBIO, which in turn drives the price of the stock up even further. How often is Mustang Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MBIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ARAV Short Interest Data BPTS Short Interest Data AGRX Short Interest Data CYCC Short Interest Data ONCO Short Interest Data VRPX Short Interest Data CYTO Short Interest Data ATXI Short Interest Data CLVR Short Interest Data NTBL Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MBIO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press